DK138791B - Analogifremgangsmåde til fremstilling af 2,6-disubstituerede fenylaminoguanidinforbindelser. - Google Patents

Analogifremgangsmåde til fremstilling af 2,6-disubstituerede fenylaminoguanidinforbindelser.

Info

Publication number
DK138791B
DK138791B DK579774AA DK579774A DK138791B DK 138791 B DK138791 B DK 138791B DK 579774A A DK579774A A DK 579774AA DK 579774 A DK579774 A DK 579774A DK 138791 B DK138791 B DK 138791B
Authority
DK
Denmark
Prior art keywords
phenylaminoguanidine
disubstituted
compounds
preparation
analogous process
Prior art date
Application number
DK579774AA
Other languages
Danish (da)
English (en)
Other versions
DK579774A (fr
DK138791C (fr
Inventor
Harm Jan Panneman
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of DK579774A publication Critical patent/DK579774A/da
Publication of DK138791B publication Critical patent/DK138791B/da
Application granted granted Critical
Publication of DK138791C publication Critical patent/DK138791C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK579774AA 1973-11-09 1974-11-06 Analogifremgangsmåde til fremstilling af 2,6-disubstituerede fenylaminoguanidinforbindelser. DK138791B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7315350A NL7315350A (nl) 1973-11-09 1973-11-09 Nieuwe aminoguanidine verbindingen.

Publications (3)

Publication Number Publication Date
DK579774A DK579774A (fr) 1975-07-07
DK138791B true DK138791B (da) 1978-10-30
DK138791C DK138791C (fr) 1979-04-09

Family

ID=19819967

Family Applications (1)

Application Number Title Priority Date Filing Date
DK579774AA DK138791B (da) 1973-11-09 1974-11-06 Analogifremgangsmåde til fremstilling af 2,6-disubstituerede fenylaminoguanidinforbindelser.

Country Status (17)

Country Link
US (1) US3972932A (fr)
JP (1) JPS5546389B2 (fr)
AR (1) AR205358A1 (fr)
BE (1) BE822019A (fr)
CA (1) CA1032962A (fr)
CH (1) CH616656A5 (fr)
DE (1) DE2452691A1 (fr)
DK (1) DK138791B (fr)
ES (1) ES431775A1 (fr)
FI (1) FI62064C (fr)
FR (1) FR2250521B1 (fr)
GB (1) GB1487852A (fr)
HU (1) HU171856B (fr)
IE (1) IE40409B1 (fr)
NL (1) NL7315350A (fr)
SE (1) SE420720B (fr)
ZA (1) ZA746701B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141992A (en) * 1975-08-22 1979-02-27 American Cyanamid Company Cycloalkylcarboxyamidines and halobenzamidines as anti-amebic agents
US4113776A (en) * 1976-04-15 1978-09-12 Hoffmann-La Roche Inc. 1-(2-Aminoethyl)-3-(2,6-dihalophenyl)guanidines
JPS5930330A (ja) * 1982-08-12 1984-02-17 Yaesu Musen Co Ltd デジタル周波数表示方式
HU190639B (en) * 1983-12-12 1986-09-29 Gyogyszerkutato Intezet Kv,Hu Process for production of new aminoguanidin derivatives
DE3581029D1 (de) * 1984-09-19 1991-02-07 Ciba Geigy Ag Substituierte carbodiimide.
ZA857153B (en) * 1984-09-19 1986-05-28 Ciba Geigy Ag Substituted carbodiimides
US5262568A (en) * 1990-03-02 1993-11-16 State Of Oregon Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
ATE220320T1 (de) 1990-03-02 2002-07-15 Oregon State Tri- und tetra-substituierte guanidine und deren verwendung als antagonisten von exzitatorischen aminosäuren
US5847006A (en) * 1991-02-08 1998-12-08 Cambridge Neuroscience, Inc. Therapeutic guanidines
CA2099245A1 (fr) * 1991-02-08 1992-08-09 Stanley M. Goldin Guanidines substituees et leurs derives en tant que modulateurs de la liberation des neurotransmetteurs et nouvelle methodologie permettant d'identifier les inhibiteurs de la liberation des neurotransmetteurs
US5741661A (en) * 1991-02-08 1998-04-21 Cambridge Neuroscience, Inc. Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
WO1994027591A1 (fr) * 1993-05-27 1994-12-08 Cambridge Neuroscience, Inc. Guanidines substituees therapeutiques
AU705487B2 (en) * 1993-11-23 1999-05-20 Cambridge Neuroscience, Inc. Therapeutic substituted guanidines
US6143791A (en) * 1994-02-03 2000-11-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
US6787569B1 (en) 1994-02-03 2004-09-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
WO1995020950A1 (fr) 1994-02-03 1995-08-10 Cambridge Neuroscience, Inc. Guanidines therapeutiques
US7351743B1 (en) 1994-02-03 2008-04-01 Wyeth Therapeutic guanidines
JP4564786B2 (ja) * 2004-06-07 2010-10-20 株式会社日本ファインケム １−置換―１―アミノグアニジン又はその塩、及びこれらの製造方法
JP4739695B2 (ja) * 2004-06-07 2011-08-03 株式会社日本ファインケム ５−アミノ―１―置換―１，２，４―トリアゾールの製造方法、及び該製造方法で得られるトリアゾール誘導体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB800869A (en) * 1955-09-28 1958-09-03 Ici Ltd Substituted amino-guanidines
NL7011683A (fr) * 1970-08-07 1972-02-09

Also Published As

Publication number Publication date
IE40409L (en) 1975-05-09
SE420720B (sv) 1981-10-26
FR2250521A1 (fr) 1975-06-06
ZA746701B (en) 1975-11-26
BE822019A (fr) 1975-05-09
SE7414045L (fr) 1975-05-12
JPS5077328A (fr) 1975-06-24
IE40409B1 (en) 1979-05-23
DK579774A (fr) 1975-07-07
US3972932A (en) 1976-08-03
FR2250521B1 (fr) 1979-03-16
ES431775A1 (es) 1976-12-16
HU171856B (hu) 1978-04-28
DE2452691A1 (de) 1975-05-15
CA1032962A (fr) 1978-06-13
FI62064B (fi) 1982-07-30
AR205358A1 (es) 1976-04-30
CH616656A5 (fr) 1980-04-15
FI324374A (fr) 1975-05-10
DK138791C (fr) 1979-04-09
FI62064C (fi) 1982-11-10
NL7315350A (nl) 1975-05-13
GB1487852A (en) 1977-10-05
JPS5546389B2 (fr) 1980-11-22

Similar Documents

Publication Publication Date Title
DK139099B (da) Analogifremgangsmåde til fremstilling af 5,6-4H-dihydro-s-triazolo(4,3-a)benzodiazepiner-1,5.
DK136718B (da) Analogifremgangsmåde til fremstilling af substituerede hexahydro-dibenzo(b,d)-pyran-9-oner.
DK136719B (da) Analogifremgangsmåde til fremstilling af substituerede hexahydro-dibenzo(b,d)-pyraner.
DK134345B (da) Analogifremgangsmåde til fremstilling af 4-hydroxymethyl-1-phthalazonderivater.
DK138791B (da) Analogifremgangsmåde til fremstilling af 2,6-disubstituerede fenylaminoguanidinforbindelser.
DK135376B (da) Fremgangsmåde til fremstilling af piperazinylquinazolin-forbindelser.
DK136075B (da) Analogifremgangsmåde til fremstilling af 11beta-hydroxy-16-methyl-3-oxo-17alfa-acyloxyandrosta-1,4,15-trien-17beta-carboxylater.
DK137277B (da) Analogifremgangsmåde til fremstilling af ferrocenforbindelser.
DK140484B (da) Fremgangsmåde til fremstilling af zeaxanthin.
DK139678B (da) Fremgangsmåde til fremstilling af 2,2,6,6-tetramethyl-4-oxopiperidin.
DK140406B (da) Fremgangsmåde til fremstilling af 2,2,6,6-tetramethyl-4-oxopiperidin.
DK135768B (da) Fremgangsmåde til fremstilling af 1-alkyl-3,5-diphenylpyrazoler.
DK137389B (da) Analogifremgangsmåde til fremstilling af 11beta-substituerede delta4-østrener.
DK135723B (da) Analogifremgangsmåde til fremstilling af 7alfa-acylthio-3-oxo-D-homo-21,24-dinor-17aalfa-chlo-4-en-23,17a-lactoner.
DK137577B (da) Fremgangsmåde til fremstilling af zeaxanthin.
DK132328B (da) Analogifremgangsmåde til fremstilling af 17beta-hydroxy-16,16-dimethylestr-4-en-3-on.
DK137043B (da) Analogifremgangsmåde til fremstilling af nitrocarbostyrilforbindelser.
DK138319B (da) Analogifremgangsmåde til fremstilling af 6-fluoralkyl-2(1H), 3(4H)-quinoxalindionforbindelser.
DK139716B (da) Analogifremgangsmåde til fremstilling af 4-aminoamfetaminderivater.
DK140480B (da) Analogifremgangsmåde til fremstilling af 2,8-substituerede D-6-alkylergoliner.
DK136619B (da) Fremgangsmåde til fremstilling af dihydrokanadensolid.
DK138895B (da) Fremgangsmåde til fremstilling af 8-beta-(2'-pyrimidino-aminometyl)-ergolinderivater.
DK137924C (da) Fremgangsmaade til fremstilling af 1,4-dihydroquinoliner
DK139910B (da) Analogifremgangsmåde til fremstilling af substituerede triazoler.
DK130829B (da) Fremgangsmåde til fremstilling af 5-nitro-1,4-naphthoquinon.